2021 연구자 정보 (17 / 1141)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Venkatanarayan, Avinashnarayan
(Venkatanarayan, A)
Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA

[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma SCIE 0.7 MULTIDISCIPLINARY SCIENCES twkimmd@amc.seoul.kr
shivam@gene.com
Venkatramanan, K.
(Venkatramanan, K)
SCSVMV Deemed Univ, Dept Phys, Kanchipuram 631561, Tamil Nadu, India N-4628-2016
kannan, venkatramanan

[JCR상위 0.7%] Current advancements on charge selective contact interfacial layers and electrodes in flexible hybrid perovskite photovoltaics SCIE 0.7 CHEMISTRY, APPLIED
CHEMISTRY, PHYSICAL
ENERGY & FUELS
ENGINEERING, CHEMICAL
SaiAnand.Gopalan@newcastle.edu.au
Quinn.Qiao@sdstate.edu
Western, Luke M.
(Western, LM)
교신저자 Univ Bristol, Sch Chem, Bristol, Avon, England
0000-0002-0043-711X
Western, Luke
[JCR상위 0.7%] A decline in emissions of CFC-11 and related chemicals from eastern China SCIE 0.7 MULTIDISCIPLINARY SCIENCES Luke.western@bristol.ac.uk
rprinn@mit.edu
matt.rigby@bristol.ac.uk
Wilson, Gregory J.
(Wilson, GJ)
Newcastle Energy Ctr, CSIRO Energy, 10 Murray Dwyer Cct, Mayfield West, NSW 2304, Australia G-3005-2013
Wilson, Gregory
0000-0003-2575-5488
Wilson, Gregory
[JCR상위 0.7%] Current advancements on charge selective contact interfacial layers and electrodes in flexible hybrid perovskite photovoltaics SCIE 0.7 CHEMISTRY, APPLIED
CHEMISTRY, PHYSICAL
ENERGY & FUELS
ENGINEERING, CHEMICAL
SaiAnand.Gopalan@newcastle.edu.au
Quinn.Qiao@sdstate.edu
Yan, Yibing
(Yan, YB)
Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA

[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma SCIE 0.7 MULTIDISCIPLINARY SCIENCES twkimmd@amc.seoul.kr
shivam@gene.com
Ye, Xin
(Ye, X)
Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA

[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma SCIE 0.7 MULTIDISCIPLINARY SCIENCES twkimmd@amc.seoul.kr
shivam@gene.com
Yen, Ivana
(Yen, I)
제1저자 Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA

[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma SCIE 0.7 MULTIDISCIPLINARY SCIENCES twkimmd@amc.seoul.kr
shivam@gene.com
Yi, Kijong
(Yi, K)
Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn GSMSE, Daejeon, South Korea

[JCR상위 0.7%] Clonal dynamics in early human embryogenesis inferred from somatic mutation SCIE 0.7 MULTIDISCIPLINARY SCIENCES ohjiwon@knu.ac.kr
ysju@kaist.ac.kr
Yin, Jianping
(Yin, JP)
Genentech Inc, Dept Struct Biol, San Francisco, CA 94080 USA

[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma SCIE 0.7 MULTIDISCIPLINARY SCIENCES twkimmd@amc.seoul.kr
shivam@gene.com
Youk, Jeonghwan
(Youk, J)
Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn GSMSE, Daejeon, South Korea

[JCR상위 0.7%] Clonal dynamics in early human embryogenesis inferred from somatic mutation SCIE 0.7 MULTIDISCIPLINARY SCIENCES ohjiwon@knu.ac.kr
ysju@kaist.ac.kr
Zhang, Liangxuan
(Zhang, LX)
Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA

[JCR상위 0.7%] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma SCIE 0.7 MULTIDISCIPLINARY SCIENCES twkimmd@amc.seoul.kr
shivam@gene.com
Acharya, Suman
(Acharya, S)
Yeungnam Univ, Coll Pharm, 280 Daehak Ro, Gyongsan 38541, Gyeongbuk Do, South Korea
Yeungnam Univ, Coll Pharm, Gyongsan, South Korea
AAP-4838-2020
Acharya, Suman

[JCR상위 0.8%] AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway
[JCR상위 29.3%] Geranylgeranyl pyrophosphate amplifies Treg differentiation via increased IL-2 expression to ameliorate DSS-induced colitis
SCIE 0.8 BIOCHEMISTRY & MOLECULAR BIOLOGY
ONCOLOGY
IMMUNOLOGY
hjko@kangwon.ac.kr
jchang@yu.ac.kr
Ahn, Jae-Hee
(Ahn, JH)
Kangwon Natl Univ, Dept Pharm, Kangwondaehak Gil 1, Chunchon 24341, South Korea

[JCR상위 0.8%] AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway SCIE 0.8 BIOCHEMISTRY & MOLECULAR BIOLOGY
ONCOLOGY
hjko@kangwon.ac.kr
jchang@yu.ac.kr
Chang, Jae-Hoon
(Chang, JH)
교신저자 Yeungnam Univ, Coll Pharm, 280 Daehak Ro, Gyongsan 38541, Gyeongbuk Do, South Korea
Yeungnam Univ, Coll Pharm, Gyongsan, South Korea


[JCR상위 0.8%] AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway
[JCR상위 29.3%] Geranylgeranyl pyrophosphate amplifies Treg differentiation via increased IL-2 expression to ameliorate DSS-induced colitis
SCIE 0.8 BIOCHEMISTRY & MOLECULAR BIOLOGY
ONCOLOGY
IMMUNOLOGY
hjko@kangwon.ac.kr
jchang@yu.ac.kr
Gu, Ye
(Gu, Y)
Yeungnam Univ, Coll Pharm, 280 Daehak Ro, Gyongsan 38541, Gyeongbuk Do, South Korea
Yeungnam Univ, Coll Pharm, Gyongsan, South Korea


[JCR상위 0.8%] AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway
[JCR상위 29.3%] Geranylgeranyl pyrophosphate amplifies Treg differentiation via increased IL-2 expression to ameliorate DSS-induced colitis
SCIE 0.8 BIOCHEMISTRY & MOLECULAR BIOLOGY
ONCOLOGY
IMMUNOLOGY
hjko@kangwon.ac.kr
jchang@yu.ac.kr
페이지 이동: